Navigation Links
Morphine Withdrawal Complicates Hepatitis C Infection in Drug Abusers

Hepatitis C, a condition that leads to inflammation of the liver is common among intravenous drug users. There are nearly 70-80 % of abusers are suffering from // the disease in the United States.

This high association has generated interest in determining the effects of drug abuse, specifically opiates, on progression of the disease. The discovery of such an association would impact treatment of both HCV infection and drug abuse. It has now been established from a recent study that morphine withdrawal complicates the Hepatitis C infection by suppressing IFN-alpha-mediated immunity and enhancing virus replication.

It has previously been shown using cell culture techniques that morphine enhances virus replication and inhibits IFN-alpha (a natural anti-viral factor produced by immune, as well as host cells, and the only one approved in recombinant form for treating HCV infection).

The researchers examined the effects of morphine withdrawal (MW) on HCV-infected cultured liver cells by exposing cells to the drug for four days followed by its removal. They also assessed the effects of using naloxone.

To measure HCV replication, they used a virus-like “replicon” that mimics the events that occur in liver cells. Although the replicon does not produce the infectious virus, the HCV replicon system represents the best available system for examining the impact of opiates on HCV at the time of the study.

It was found that there was an increase in the number of HCV replicon in both the withdrawal scenario. Furthermore, there was an inhibition of the IFN-alpha expression in liver cells in the presence or absence of HCV replicon in both the cases.

Since IFN-alpha is a critical self-defense mechanism utilized by liver cells to fight off viral infection, including HIV, this study suggests that morphine withdrawal weakens host cell immunity and provides a favorable environment for HCV growth in the liver. The s
'"/>




Page: 1 2

Related medicine news :

1. Morphine may excite cancerous tumors
2. Using Morphine to Hasten Death Is a Myth, Says Doctor
3. How Morphine Affects Memory
4. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
5. Hospital Services Still Paralysed Inspite Of The Withdrawal Of The Strike
6. Risk Of Death Increases With Sudden Withdrawal Of Medications
7. Sudden Opioid Withdrawal Results in ‘Broken Heart Syndrome
8. Cadbury Dismisses Rumors of Withdrawal of More Products
9. Andhra Wants Withdrawal of Warning Signal from ‘Beedi’ Packes
10. HIV Testing Improves After Withdrawal of Consent Letter
11. FDA Announces Voluntary Withdrawal of Pergolide Products

Post Your Comments:
(Date:12/4/2009)...kDesk Inventor Showcasing Innovative Health Produc... December 4, 2009 -- A valley inventor garnering n... individuals lose weight, prevent disease, restore...be showcasing the product at Saturday’s Tech..., , , , TrekDesk has been featured on major tele...
(Date:12/4/2009)... Fla., Dec. 4 NeoGenom...oday that Steven C. Jones has been appointed Execu...rdoza has joined the company as Chief Financial Of...ng all internal financial affairs of the Company. ...ng strategic initiatives on behalf of NeoGenomics ...
(Date:12/4/2009)... 4 The following is an ...amily Philanthropies: ,, Credit Senators John K...cant contribution to the health care debate: a bil...ving with Phenylketonuria (PKU) control their pote...ving with serious chronic conditions are treated. ...
(Date:12/4/2009)...her pollution levels, though risks are unclear , ...orporate and private jets take off and land at sma...st fills the air with small particles of combustio...arby, suggests a new study by California researche...ized as a problem near major airports, far less re...
(Date:12/4/2009)...la., Dec. 4 , ,What: Hum...edicare, health benefits provider, i...managames.com ), a senior-friendly dance pad, ...ter on Tues., Dec. 8 at 1 p.m. The ... and open to the public, will feature Dancetown, ...
Breaking Medicine News(10 mins):Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:NeoGenomics Announces Executive Appointments 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Smaller Airports May Endanger Health 2Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2
...oration (Nasdaq: RURL ) issued another reminder t...re of the Company,s common stock in relation,to it...rship rules under,Section 382 of the U.S. Internal...ng a change in ownership of,the corporation. Secti...
...ocial Security Disability Insurance Should Know Th... Questions , Belleville, ...ves with a mental or physical disability face many...ges, the past still plays a role in the future, es...
...ecialists, a leader in Cardiology and Gastroentero...;s leading provider of medical transcription servi...ical transcription provider for accurate and timel...cal transcription services to healthcare clinics, ...
... percentage of African American ...Keeping a food diary can double,a person,s weight ... Center,for Health Research. The findings, from on...reventive Medicine., Funded by the National Heart...
...l months,senior leadership at Anthem Blue Cross ha...with the California Department of Managed Health C...vious rescissions. I,personally have been negotiat... are the key elements of our settlement proposal:,...
...,("Ventas" or the "Company") announced today that ...ease after the close of trading on Tuesday,August ...gs will be held on,Wednesday, August 6, 2008 at 10...asreit.com or at, http://www.earnings.com ., Ven...
Other Medicine News:Health News:Rural/Metro Issues Reminder to Stockholders on Transactions That May Impact IRS Section 382 Outcome 2Health News:Rural/Metro Issues Reminder to Stockholders on Transactions That May Impact IRS Section 382 Outcome 3Health News:Past Earnings Play Role in Determining SSDI Benefits 2Health News:Past Earnings Play Role in Determining SSDI Benefits 3Health News:Past Earnings Play Role in Determining SSDI Benefits 4Health News:Past Earnings Play Role in Determining SSDI Benefits 5Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 2Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 2Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 4Health News:Anthem Blue Cross Statement on Settlement Discussions with the California Department of Managed Health Care 2
(Date:12/3/2009)..., , NEW YORK, Dec. 3 Gu...firm, today announced the launch of their Sleep Ap...hat monitors and projects trends and market share ...eep Apnea Tracker captures actual patient usage fo... United States from 15 different equipment provide...
(Date:12/3/2009)..., , SUNNYVALE, Calif., Dec. 3 /PRNewswir... ), a biopharmaceutical company focused on develop...drugs for the treatment of immune mediated disease...webcast and conference call on, Tuesday, December ...ime and 8:00am Pacific Time) to discuss clinical d...
(Date:12/3/2009)..., , WILMINGTON, Del., Dec. 3 /PRNewswir...zing in pharmaceutical risk management and optimal...sday, Dec. 9, on the FDA,s draft guidance on REMS ...nd its implications for REMS lifecycle management....nRx and an expert on REMS and risk management prog...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2PharmSource Releases White Paper on Role of U S Foreign Corrupt Practices Act 28FCPA 29 in the Bio Pharma Industry 12931 1PharmSource Releases White Paper on Role of U S Foreign Corrupt Practices Act 28FCPA 29 in the Bio Pharma Industry 12931 2PharmSource Releases White Paper on Role of U S Foreign Corrupt Practices Act 28FCPA 29 in the Bio Pharma Industry 12931 3Vancouver Fertility Acupuncture Clinic Announces New Fellows of the American Board of Oriental Reproductive Medicine 51025 1Vancouver Fertility Acupuncture Clinic Announces New Fellows of the American Board of Oriental Reproductive Medicine 51025 2Vancouver Fertility Acupuncture Clinic Announces New Fellows of the American Board of Oriental Reproductive Medicine 51025 3New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product 51020 1New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product 51020 2
... a First-in-Class Biologic Treatment Option Now Av...s with JIA(1,2) -, PRINCETON, N.J., April 8, 2008... announced that the U.S. Food and Drug,Administrat...reducing signs,and symptoms in pediatric patients ...tive polyarticular juvenile idiopathic arthritis (...
...d., April 8, 2008 ImQuest scientists Robert,W. Bu...nted the results of,studies performed with product...ecent Microbicides 2008, an international conferen...icide scientists, developers, and care,givers from...ak by the,Conference organizers, presenting the re...
Other Medicine Technology:U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 2U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 3U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 4U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 5U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 6U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 7U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 8U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 9U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 10ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India 2
Genu-Lite Knee Support
GenuTrain
Exotec® Dual Instabilities Lite
...atellar Brace is a support designed to treat patel... aircell stabilizes the patella and compresses the... the patella. During ambulation, the aircell also ...welling and pain. A moveable aircell is included t...
Medicine Products: